Replies to post #19298 on BioCurex, Inc.(fka BOCX)

[mata hari]

the science is cutting edge. it takes time to educate the educated. because the science works, bocx holders need not worry about this rough patch (looks like the storm has passed by) and especially not fall for the obvious stock manipulation that has gone on for too long.

[Gold Seeker]

Opportunity, I notice you did not give the links to the material you posted. I found the first to be a company press release. Doesn't count. Try again.

[Gold Seeker]

Opportunity stated: "Did you know that Goshen was working on a rapid saliva test before they published their preliminary results?"

It is not a rapid test. Moro used a modified chemiluminescence assay .

Now, read the rules again. You cannot use company material, press releases, publications or other company material to support an attempt to validate the usefulness of RECAF.

All you need to do is produce one independent statement from a reputable source stating there is a huge need for RECAF. Also, any statement by a reputable cancer organization even talking about the merits of RECAF.

BTW, when searching RECAF, all I ever find is press releases, paid hype attempting to sell stock. There is absolutely NOTHING out there discussing the merits of RECAF that is independent of the company.

I do not want something that says the test works because I know the test can detect cancer cells. I want some independent information tha the test will actually be useful in the fight against cancer